Accelerating Pharma MLR Compliance
AI-assisted content review ensures alignment with brand, medical, legal, and regulatory standards in days, not months: A stealth-stage AI startup set out to transform one of pharma’s most complex bottlenecks: Medical, Legal, and Regulatory (MLR) content review. With interest from top 10 global pharma companies, the opportunity was clear—speed up the review of marketing and […]
Business strategy and portfolio planning for a life sciences discovery platform
A global genomics company was looking to shape its research offering to build a business in the life sciences drug discovery space. We created the commercial plan, prototype-validated the workflows for bioinformaticians and population geneticists, and collaborated to both build and launch the solution. The result was a successful global business, serving population projects and […]
Validating and implementing a next-gen LIMS to drive global scientific innovation
AbbVie’s multiple legacy LIMS systems were difficult to use and differed between teams and even countries, reducing productivity and collaboration. We conducted 51 interviews across functional areas and regional R&D groups, yielding consensus best practices that could be standardized and pushed out organization-wide. Applying the validated experiences and input of company scientists, we collaborated with […]
Growing a genomic diagnostic testing business for rare disease 10X in one year
This pathbreaking rare disease diagnostics business had been and was now looking to accelerate sales. Of primary importance was unlocking untapped adoption potential with genetic counselors and pediatric neurologists. We engaged clinicians and key decision-makers, and in one month validated the top barriers in both the purchase journey and product experience. Through rapid, iterative testing […]
Framing and launching a new, user-centered carrier test business
A global genomics company, WuXiNextCODE, had already been successful with other businesses focused on whole genome sequencing. Their next focus was serving the NIPT market, and they looked to us to validate the key personas, critical user experience components, and then design and launch the detailed experience for parents, OB/GYNs, and additional family members. In […]
Launching a global consumer genomic business
What was missing from consumer genomic experiences to make them meaningful, valuable, and actionable to users? We found out. We validated through extensive prototype user testing, and created for global use, experiences built for physicians and patients to review truly actionable insights from consumer genomic data. Launched initially in China, this offering was leveraged across […]
Creating a new RWD/RWE product portfolio to drive sales in life sciences
Our client needed help to define, validate, and launch its first portfolio of RWD and RWE life sciences offerings, including clinical trial design, outcomes research portfolio planning, FDA submission, reimbursement approval acceleration, and commercial sales acceleration. The portfolio was designed, market-validated and launched. Time-to-close sales contracts was reduced 40%. Sales increased by multiples at customers […]
AI-Enabled Health Record Assistant
Transforms health history for patients into clear, actionable insights through conversational AI: A digital health startup asked: What if anyone could understand their own medical records—without needing a physician to explain them? With rising demand for accessible care guidance, they envisioned an AI-powered experience that could interpret a person’s health history and surface relevant next […]
Business strategy and fundraising for a global NGS company
We collaborated with executive management to shape and deliver the combined corporate and fundraising strategy, founded in a positioning as a global platform both enabling and delivering solutions across all of genomics and the globe. Results included a raise of $240M and a growing portfolio of seven businesses.